These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 11570274

  • 21. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV, Pavliuk TD.
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of baicalein against Candida albicans biofilms.
    Cao Y, Dai B, Wang Y, Huang S, Xu Y, Cao Y, Gao P, Zhu Z, Jiang Y.
    Int J Antimicrob Agents; 2008 Jul; 32(1):73-7. PubMed ID: 18374543
    [Abstract] [Full Text] [Related]

  • 23. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
    Mai A, Rotili D, Massa S, Brosch G, Simonetti G, Passariello C, Palamara AT.
    Bioorg Med Chem Lett; 2007 Mar 01; 17(5):1221-5. PubMed ID: 17196388
    [Abstract] [Full Text] [Related]

  • 24. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.
    Mukherjee PK, Long L, Kim HG, Ghannoum MA.
    Int J Antimicrob Agents; 2009 Feb 01; 33(2):149-53. PubMed ID: 18945596
    [Abstract] [Full Text] [Related]

  • 25. Susceptibility of Candida albicans filamentation-defective mutants to clinical biocides.
    Watamoto T, Samaranayake LP, Egusa H, Yatani H, Samaranayke YH, Seneviratne CJ.
    J Hosp Infect; 2010 Feb 01; 74(2):189-91. PubMed ID: 20061059
    [No Abstract] [Full Text] [Related]

  • 26. Action of miconazole at high concentrations against Candida albicans.
    D'Auria FD, Villa A, Simonetti N.
    J Chemother; 1989 Jul 01; 1(4 Suppl):240-2. PubMed ID: 16312385
    [No Abstract] [Full Text] [Related]

  • 27. Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
    Li XC, Jacob MR, ElSohly HN, Nagle DG, Smillie TJ, Walker LA, Clark AM.
    J Nat Prod; 2003 Aug 01; 66(8):1132-5. PubMed ID: 12932143
    [Abstract] [Full Text] [Related]

  • 28. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
    Balaban N, Karahan ZC, Mumcuoğlu I, Cayirli A, Kuştimur S.
    Mikrobiyol Bul; 2007 Apr 01; 41(2):245-51. PubMed ID: 17682711
    [Abstract] [Full Text] [Related]

  • 29. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P, Park S, Perlin D, Kubin C, Della-Latta P.
    J Clin Microbiol; 2004 Dec 01; 42(12):5938-9. PubMed ID: 15583347
    [Abstract] [Full Text] [Related]

  • 30. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM, Prigitano A, Biraghi E, Viviani MA, FIMUA-ECMM Candidaemia Study Group.
    J Antimicrob Chemother; 2005 Oct 01; 56(4):777-9. PubMed ID: 16144871
    [Abstract] [Full Text] [Related]

  • 31. Integrated antifungal drug discovery in Candida albicans.
    Sanglard D.
    Nat Biotechnol; 2001 Mar 01; 19(3):212-3. PubMed ID: 11231545
    [No Abstract] [Full Text] [Related]

  • 32. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD.
    J Antimicrob Chemother; 2004 Dec 01; 54(6):999-1006. PubMed ID: 15486081
    [Abstract] [Full Text] [Related]

  • 33. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E, Costa-de-Oliveira S, Dias AS, Guerra J, Rodrigues AG, Pina-Vaz C.
    FEMS Yeast Res; 2009 Jun 01; 9(4):618-25. PubMed ID: 19416368
    [Abstract] [Full Text] [Related]

  • 34. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
    Jainkittivong A, Butsarakamruha T, Langlais RP.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep 01; 108(3):394-8. PubMed ID: 19716507
    [Abstract] [Full Text] [Related]

  • 35. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents.
    Baillie GS, Douglas LJ.
    J Antimicrob Chemother; 2000 Sep 01; 46(3):397-403. PubMed ID: 10980166
    [Abstract] [Full Text] [Related]

  • 36. Propranolol inhibits Candida albicans adherence and biofilm formation on biotic and abiotic surfaces.
    Derengowski Lda S, Pereira AL, Andrade AC, Kyaw CM, Silva-Pereira I.
    Int J Antimicrob Agents; 2009 Dec 01; 34(6):619-21. PubMed ID: 19801180
    [No Abstract] [Full Text] [Related]

  • 37. Polyene resistant Candida albicans: a proposed nutritional influence.
    Hammond SM, Kliger BN.
    Microbios; 1974 Apr 01; 10(38):97-101. PubMed ID: 4604922
    [No Abstract] [Full Text] [Related]

  • 38. [Sensitivity of Candida albicans to antimycotic antibiotics and chemotherapeutic agents].
    Pospísil J, Otcenásek M.
    Bratisl Lek Listy; 1987 Sep 01; 88(3):336-43. PubMed ID: 3311299
    [No Abstract] [Full Text] [Related]

  • 39. [Resistance against Candida is a current problem].
    Osterlund A, Strand A.
    Lakartidningen; 1998 Oct 07; 95(41):4476-7. PubMed ID: 9803739
    [No Abstract] [Full Text] [Related]

  • 40. [Strain variations of Candida albicans and sensitivity to antifungal agents].
    Casal Román M, Linares Sicilia MJ, Blanco Domínguez CM.
    Med Clin (Barc); 1987 Jun 13; 89(3):129. PubMed ID: 3306187
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.